Sarepta Therapeutics Inc (SRPT)

Exchange
NASDAQ
Symbol
SRPT
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: September 24, 2025

  • Open
    18.15
  • High
    18.46
  • Low
    17.51
  • Close
    18.26
  • Volume
    5,095,550

Financial ratios

Dec 31, 2024